ArticlePDF Available

FcεRIα gene -18483A>C polymorphism affects transcriptional activity through YY1 binding

Authors:

Abstract and Figures

Three frequent genetic polymorphisms in the human high-affinity IgE receptor alpha-subunit (FcepsilonRIalpha) were shown to be associated with allergic disorders and/or total serum IgE levels in allergic patients. Two of these were previously demonstrated to affect FcepsilonRIalpha expression while the third -18483A>C (rs2494262) has not yet been subjected to functional studies. We hypothesized that the -18483A>C variant affects transcriptional activity of the FcepsilonRIalpha distal promoter in monocytes in which FcepsilonRIalpha transcription is driven through that regulatory region. Indeed, we confirmed preferential binding of the YY1 transcription factor to the -18483C allele, resulting in lower transcriptional activity when compared with the -18483A allele.
Content may be subject to copyright.
BRIEF COMMUNICATION
FcεRIαgene 18483A>C polymorphism affects
transcriptional activity through YY1 binding
Daniel P. Potaczek &Keiko Maeda &Qing-Hui Wang &Nobuhiro Nakano &
Shunsuke Kanada &Ewa Stepien &Agnieszka Branicka &Tatsuo Fukai &
Mutsuko Hara &Tomoko Tokura &Hideoki Ogawa &Anetta Undas &Ko Okumura &
Chiharu Nishiyama
Received: 13 April 2009 / Accepted: 27 July 2009 /Published online: 14 August 2009
#Springer-Verlag 2009
Abstract Three frequent genetic polymorphisms in the
human high-affinity IgE receptor α-subunit (FcεRIα) were
shown to be associated with allergic disorders and/or total
serum IgE levels in allergic patients. Two of these were
previously demonstrated to affect FcεRIαexpression while
the third 18483A>C (rs2494262) has not yet been
subjected to functional studies. We hypothesized that the
18483A>C variant affects transcriptional activity of the
FcεRIαdistal promoter in monocytes in which FcεRIα
transcription is driven through that regulatory region.
Indeed, we confirmed preferential binding of the YY1
transcription factor to the 18483C allele, resulting in lower
transcriptional activity when compared with the 18483A
allele.
Keywords FcεRIα.Monocytes .Polymorphism .
YY1 .FCER1A
Considering the crucial role of the human high-affinity IgE
receptor (FcεRI; Zhang et al. 2007), it is not surprising that
Supported by a research grant from the Japan Society for the
Promotion of Science (JSPS)
Supported by a grant-in-aid for Scientific Research (C) from the
Ministry of Education, Culture, Sports, Science, and Technology of
Japan
Electronic supplementary material The online version of this article
(doi:10.1007/s00251-009-0391-x) contains supplementary material,
which is available to authorized users.
D. P. Potaczek :K. Maeda :Q.-H. Wang :N. Nakano :
S. Kanada :T. Fukai :M. Hara :T. Tokura :H. Ogawa :
K. Okumura :C. Nishiyama (*)
Atopy (Allergy) Research Center,
Juntendo University School of Medicine,
2-1-1 Hongo, Bunkyo-ku,
Tokyo 113-8421, Japan
e-mail: chinishi@juntendo.ac.jp
Q.-H. Wang
Department of Immunology, College of Basic Medical Sciences,
China Medical University,
No. 92 Beier Road, Heping District,
Shenyang 110001, China
S. Kanada :K. Okumura
Department of Immunology,
Juntendo University School of Medicine,
2-1-1 Hongo, Bunkyo-ku,
Tokyo 113-8421, Japan
E. Stepien :A. Branicka
John Paul II Hospital,
80 Pradnicka Str.,
31-202 Krakow, Poland
T. Fukai
Department of Dermatology,
Juntendo University School of Medicine,
2-1-1 Hongo, Bunkyo-ku,
Tokyo 113-8421, Japan
A. Undas
Institute of Cardiology,
Jagiellonian University School of Medicine,
80 Pradnicka Str.,
31-202 Krakow, Poland
Immunogenetics (2009) 61:649655
DOI 10.1007/s00251-009-0391-x
FcεRI α-subunit (FcεRIα) gene variability was recently
studied in the context of allergies and allergic disorders.
FcεRIα344(315)
1
C>T (rs2427827) polymorphism was
found to be associated with aspirin-induced urticaria (Bae et
al. 2007) and with total serum IgE levels in different groups
of allergic subjects (Shikanai et al. 2002; Potaczek et al.
2006,2007a,2007b; Bae et al. 2007). Its close genomic
neighbor, FcεRIαproximal promoter 95(66)
1
T>C
(rs2251746) polymorphism, was shown to be associated
with atopic dermatitis (Hasegawa et al. 2003b). Both of
these frequent polymorphisms were demonstrated to
strongly affect FcεRIαexpression in mast cells and/or
basophils in an additive manner (Hasegawa et al. 2003b;
Bae et al. 2007; Kanada et al. 2008), thus providing a
partial mechanistic background for the genetic associations
described above. In addition, the frequent 18483A>C
(rs2494262) polymorphism was also found to be associated
with total serum IgE levels in allergic subjects (Potaczek et
al. 2007a,2007b); however, no functional studies on that
genetic variant have been conducted to date. Here, we
report the results of functional analysis of FcεRIα
18483A>C polymorphism.
The FcεRIαgene is composed of five coding exons,
spanning about 6 kbp, directly preceded by the proximal
promoter while two additional untranslated exons (1A and
2A) are localized further upstream (about 12 and 18 kbp,
respectively; Nishiyama et al. 2001) and are under
transcriptional regulation of the distal promoter (Hasegawa
et al. 2003a; Fig. 1a). In contrast to basophils and/or mast
cells, in which the proximal promoter strongly works with
the GATA-1/PU.1 transcription factor-dependent activating
mechanism, in monocytes, transcription of FcεRIαis also
driven by the distal promoter (Hasegawa et al. 2003a).
Hence, in monocytes, any potential effects of 18483A>C
single-nucleotide polymorphism (SNP) on FcεRIαexpres-
sion through the distal promoter would not be easily
masked by strong activity of the proximal promoter and
the potent effects of 95T>C and/or 344C>T proximal
promoter polymorphisms (Hasegawa et al. 2003b; Bae et al.
2007; Kanada et al. 2008).
Coverage of the FcεRIαgene by the 18483A>C,
344C>T, and 95T>C polymorphisms is shown in
Fig. 1a. Linkage disequilibrium (LD) data between FcεRIα
1
Polymorphisms in the present study are numbered according to the
translation start site; 95T>C and 344C>T polymorphisms were also
numbered according to the FcεRIαgene proximal promoter transcrip-
tion start site as 66T>C and 315C>T, respectively (Hasegawa et al.
2003b; Kanada et al. 2008).
b
a
Polish
population
Japanese
population
D’ D’
r
2
r
2
c
Fig. 1 Human high-affinity IgE receptor α-subunit (FcεRIα) gene
18483A>C, 344C>T, and 95T>C polymorphisms. aCoverage of
FcεRIαgene by the three polymorphisms. bLinkage disequilibrium
data between the three FcεRIαpolymorphisms in Poles (n= 104) and
Japanese (n=102). D' values are plotted on the results of four game
test (cutoff value=0.0). D' is expressed as a percentage of maximal
value (1.0). Squares without numbers correspond to D'= 1.0. White
boxes indicate four possible two-marker haplotypes, whereas black
boxes correspond tothree pairwise gametes. On the r
2
value plot,
numbers represent r
2
values expressed as a percentage of maximal
value (1.0). Squares without numbers correspond to r
2
=1.0. Shading
represents r
2
magnitude with a black-to-white gradient reflecting
higher-to-lower r
2
values. cThree FcεRIαpolymorphisms and their
haplotypes in Poles (n=104) and Japanese (n=102). Minor allele
frequencies of polymorphisms and proportions of haplotypes are
given. SNP denotes single-nucleotide polymorphism
650 Immunogenetics (2009) 61:649655
18483A>C, 344C>T, and 95T>C SNPs, estimated in
representative population groups of Polish Caucasians (n=
104) and Japanese East Asians (n=102), are presented
Fig. 1b while the allelic frequencies and the distribution of
haplotypes of the three FcεRIαpolymorphisms are given
in Fig. 1c. In all cases, three pairwise haplotypes of
18483A>C, 344C>T, and 95T>C polymorphisms
account for 97.7100.0% of all haplotypes (Fig. 1c). In
addition, all of the pairwise D' values are high, ranging
from 0.851.0 (Fig. 1b). Therefore, it can be assumed that
protein U937 nuclear extract
competitor
- A C - C A
probe A C protein U937 in vitro
probe C
extract YY1 empty
Ab
Sp1
YY1
Sp1
YY1
Sp1
YY1
---
protein THP1 nuclear extract
competitor
- A C - C A
probe A C
Ab
IgG
YY1
12 3 4 5 6 7 8 9 10 12 3 4 5 6 7 8 9
12 3 4 5 6 7 8 9 10 11 12
abc
Fig. 2 Effect of human high-affinity IgE receptor α-subunit (FcεRIα)
gene 18483A>C polymorphism on transcription factor binding on
electrophoretic mobility shift assay (EMSA). aEffects of 18483A>C
polymorphism on EMSA profile and preferential 18483C allele
protein binding in U937 cells. EMSA was performed with FITC-
labeled 18494/18471 double-stranded oligonucleotide probes car-
rying 18483A allele (lane 1)or18483C allele (lane 6) and nuclear
extracts from U937. For competition assay, 25- or 50-fold levels of
18483A (lanes 2,3,9, and 10)or18483C (lanes 4,5,7, and 8)
competitors were used. Specific bands are indicated with by arrow-
heads.bIdentification of protein preferentially binding to 18483C
allele. A mixture of 18483C probe and nuclear extract from U937
was applied into wells 13 after addition of each antibody (Ab). Lane
1without Ab, lane 2 with anti-YY1 Ab, lane 3 with irrelevant anti-
Sp1 (control) Ab. Specific bands are indicated by arrowheads.
Binding of in vitro-translated YY1 to the 18483C probe (lanes 4
9). The 18483C probe was mixed with in vitro-translated YY1 (lanes
46) or with in vitro transcription/translation mixture without template
cDNA (lanes 79). Lanes 4 and 7without Ab, lanes 5 and 8with anti-
YY1 Ab, lanes 6 and 9with irrelevant anti-Sp1 (control) Ab. cEffects
of 18483A>C polymorphism on EMSA profile and preferential
18483C allele protein binding in THP-1 cells (lanes 110). Lanes 1
10 identical description as for the left panel, except for the usage of
THP-1 nuclear extracts instead of those obtained from U937 cells.
Identification of protein preferentially binding to 18483C allele in
THP-1 (lanes 11 and 12). Lane 11 with IgG isotype control Ab, lane
12 with anti-YY1 Ab
Fig. 3 Genomic neighborhood of 18483A>C polymorphism (18470/
18499) aligned with YY1 consensus binding sequences as described by
Shrivastava and Calame (1994). Nucleotides are numbered 1to 30 for
the purposes of the present figure only. If the 18483C allele is present,
the sequence almost perfectly correlates with the YY1 consensus
repressor binding motif (Shrivastava and Calame 1994). C in position
19 of the genomic sequence does not fit T in the consensus motif;
however, the consensus rate for T in that position is 72%, and C can be
present in the YY1 binding repressor site (Shrivastava and Calame
1994). Nucleotides corresponding to the core of the YY1 binding motif
are underlined (Javahery et al. 1994). Replacement of first the C in the
core motif with A (position 14), corresponding to the 18483CA
substitution, leads to a 3- to 4-fold reduction in YY1 binding (Javahery
et al. 1994)
Immunogenetics (2009) 61:649655 651
there were no past pairwise recombination events (344C>T|
95T>C in Poles and Japanese and 18483A>C|95T>C in
Japanese) or that their rates were low (18483A>C|344C>T
in Poles and Japanese and 18483A>C|95T>C in Poles).
As a result, only four three-loci haplotypes account for
98.4% and 97.7% of all three-locus haplotypes in Poles and
Japanese, respectively (Fig. 1b, c).
In most cases, high D' values are not, however,
accompanied by r
2
values of a similar magnitude, which
reflects the substantial pairwise differences in allelic
frequencies between FcεRIαSNPs particularly for pairs
including the 95T>C SNP in Japanese (Fig. 1b, c). One
exception is the r
2
value for the 18483A>C|344C>T pair
in Poles, although this is diminished by the presence of
recombinant haplotype 18483A|344 T (1.0%), despite
the pairwise difference in allelic frequencies between
18483A>C and 344C>T SNPs in that ethnic group being
relatively small. Nevertheless, in both Caucasians and East
Asians, the genomic relationships between the three
FcεRIαSNPs are close as reflected by the distribution of
haplotypes and high D' values.
The FcεRIα18483A>C, 344C>T, and 95T>C SNPs
were genotyped by the polymerase chain reaction-
restriction fragment length polymorphism method, the
details of which can be found in the Supplementary
Materials. The structure and distribution of haplotypes
were analyzed using Thesias_3.1 software (http://genecan
vas.ecgene.net/uploads/Thesias_Java_interface/) (Tregouet
and Garelle 2007) while measures of LD were estimated
using Haploview_4.0 software (http://www.broad.mit.edu/
haploview/haploview-downloads; Barrett et al. 2005).
We speculated that the FcεRIα18483A>C polymor-
phism affects the transcriptional activity of the distal
promoter localized immediately upstream (Nishiyama et
al. 2001; Hasegawa et al. 2003a). To verify our hypothesis,
we examined the potential of the 18483A>C polymor-
phism to affect the binding of transcription factors using
electrophoretic mobility shift assay (EMSA) as described
previously (Kanada et al. 2008; Fig. 2). Oligonucleotides,
antibodies, and basic vectors used in the present study are
shown in Supplementary Materials.
EMSA conducted using nuclear extracts from human
monocytic U937 cells with competitive oligonucleotides
showed preferential binding of nuclear protein(s) to the
18483C allele (Fig. 2a). Thus, we analyzed the sequence
surrounding the 18483C allele and noted that it almost
perfectly matched the YY1 binding consensus repressive
motif while its homology to the consensus YY1 activating
site was comparatively low (Shrivastava and Calame 1994;
Fig. 3). Indeed, subsequent EMSA with specific antibodies
confirmed that the transcription factor binding to 18483C
allele was YY1 (Fig. 2b), which was further confirmed
using in vitro translated YY1 protein (Fig. 2b) obtained as
described previously (Hasegawa et al. 2003a; Kanada et al.
2008). Similar results were obtained using nuclear extracts
from human monocytic THP-1 cells (Fig. 2c).
In order to confirm YY1 binding in vivo, we performed
chromatin immunoprecipitation (ChIP) assay as described
previously (Wang et al. 2008). ChIP assay was conducted
using U937 cells confirmed by direct sequencing (Potaczek
et al. 2008) to possess 18483CC (Fig. 4). Significantly
larger amounts of chromosomal DNA around 18483 were
immunoprecipitated by YY1 antibody (Ab) as compared
with control Ab, which demonstrated the occurrence of
YY1 binding around the 18483C allele in vivo (Fig. 4,
center). Although two cis-control regions at 350 bp
upstream (Fig. 4, left) and downstream (Fig. 4, right)
exhibited significant binding with YY1, possibly due to the
presence of YY1-bindable sequences (marked with stars;
Nishiyama et al. 2001; Hasegawa et al. 2003a), the SNP
site showed the highest amount, thus suggesting that
detection of the SNP site was not dependent on YY1
binding to the YY1 sequences in the distal promoter and in
intron 1A. One cannot, however, exclude the possibility
that some of the SNP site detection was derived from the
fragments containing binding motifs in the distal promoter
or intron 1A.
YY1 Cnt YY1 Cnt YY1 Cnt
cis-control
(upstream)
cis-control
(downstream)
SNP site
Ex 1A
Relative input unit (%)
FCER1A
0.05
0.04
0.03
0.02
0.01
0
Fig. 4 In vivo binding of YY1 around the human high-affinity IgE
receptor α-subunit (FcεRIα) gene (FCER1A)18483C allele in U937
cells having the 18483CC genotype. The amount of exon 1A region
(18546/18435) immunoprecipitated with anti-YY1 antibody (Ab)
was quantitatively analyzed by chromatin immunoprecipitation assay.
Two regions upstream (18901/18753) and downstream (18117/
18015) were also analyzed. Black stars in the schematic drawing of
FCER1A gene represent the locations of identified YY1-binding
sequences in previous studies [upstream (Hasegawa et al. 2003a) and
downstream (Nishiyama et al. 2001)] and in the present study (SNP).
The results are expressed as means +SEM for three real-time PCRs
with duplicate samples. Similar results were observed in an additional
independent experiment. Closed bars specific YY1 Ab, open bars
control Ab (Cnt)
652 Immunogenetics (2009) 61:649655
Next, we examined the potential effects of 18483A>C
substitution on transcriptional activity by performing lucifer-
ase reporter assay as described previously (Kanada etal. 2008;
Wang et al. 2008). We used tandem repeated constructs
based on the pGL4.23 [luc2/miniP] plasmid to evaluate the
effect of this SNP on transcriptional activity. Briefly, triple
motif CCT(A/C)CATGCTACTAAG (18486/18471), con-
taining the 18483A>C polymorphism within its genomic
neighborhood and covering in length for repressive or
activator YY1 consensus binding sites (Shrivastava and
Calame 1994), was XhoI/HindIII subcloned upstream of the
minimal promoter of pGL4.23 [luc2/miniP] plasmid. In
human monocytic THP-1 cells, the luciferase activity of the
18483C allele-specific construct was significantly lower
when compared with that of both the 18483A allele-
specific construct and the basic (containing no genomic
insert) plasmid (Fig. 5a).
Confirmatory analyses were conducted in human baso-
philic KU812 cells (Fig. 5b), rat basophilic RBL-2H3 cells
(Fig. 5c), and mouse mastocytic PT18 cells (Fig. 5d). In all
cases, reporter activity of the 18483C allele-specific vector
Fig. 5 Effects of FcεRIαgene 18483A>C polymorphism on
transcriptional activity analyzed by luciferase assay using pGL4.23
[luc2/miniP]-based constructs in human monocytic THP-1 cells (a),
human basophilic KU812 cells (b), rat basophilic RBL-2H3 cells (c),
and mouse mastocytic PT18 cells (d). Triple motif CCT(A/C)
CATGCTACTAAG (18486/18471), containing the 18483A>C
polymorphism within its genomic neighborhood, was cloned upstream
of the minimal promoter of pGL4.23 [luc2/miniP] plasmid. Basic
plasmid denotes the pGL4.23 [luc2/miniP] vector with no genomic
insert. Relative luciferase activity is represented as the ratio of activity
to that of the basic pGL4.23 [luc2/miniP] plasmid. The results are
expressed as means +SEM for four (a), three (d), or two (b,c)
independent experimental series conducted in triplicate. One-way
ANOVA followed by post hoc Duncan's test was used for compar-
isons. Only significant results (P<0.05) on post hoc testing are shown
Relative Luciferase Activity
Cnt YY1 Cnt YY1 Cnt YY1
Basic 18483A 18483C
P
= 0.002
1.5
1
0.5
0
Fig. 6 Effects of YY1 siRNA on 18483C allele-mediated transcrip-
tional suppression. Each reporter plasmid of pGL4.23-based series
was introduced with YY1 siRNA or control siRNA using Nucleo-
fector II. YY1 siRNA significantly upregulated C-allele vector-driven
activity (P<0.005 on unpaired Student's ttest). Significant differences
between the A-allele (Cnt) and C-allele (Cnt; P<0.025 on post hoc
Duncan's test) were eliminated by YY1 siRNA treatment [P= 0.18
between A-allele (YY1) and C-allele (YY1)]
Immunogenetics (2009) 61:649655 653
was significantly lower when compared with that of both
the 18483A allele-specific construct and the basic plasmid
(Fig. 5bd). In KU812 and PT18 cells, the luciferase activity
of the 18483A allele-specific vector was also lower when
compared with that of the basic plasmid (Fig. 5b, d). If the C
allele is present in the 18483 locus, the nucleotide sequence
surrounding the 18483A>C polymorphism possesses strong
homology with the YY1 recognition repressor sequence
(Shrivastava and Calame 1994) while replacement of C by A
in the core YY1 binding motif, corresponding to replacement
of the 18483C allele by the 18483A variant, results in a 3
4-fold reduction in YY1 binding (Javahery et al. 1994;
Fig. 3). Therefore, YY1 binding to the 18483C allele would
be expected to result in a lower transcription rate when
compared with the 18483A allele. Indeed, in all four cell
lines, the luciferase activity of the 18483C allele-specific
vector was lower when compared with both the 18483A
allele-specific and basic vectors (Fig. 5ad).
In the case of KU812 and PT18 cells, 18483A allele-
specific constructs also demonstrated lower luciferase activ-
ity when compared with the basic vector (Fig. 5b, d). This
may be explained by low-affinity binding of the YY1
transcription factor to the 18483A allele, which could be
also observed in EMSA (Fig. 2a, c), resulting in a repressive
effect on transcriptional activity in some cells. Nevertheless,
in all the cases, luciferase activity of 18483C allele-specific
constructs was lower than that of 18483A allele-specific
vectors (Fig. 5ad). Although the 18483A>C polymor-
phism is located downstream of the distal promoter
transcription start site, it would not be surprising that binding
of YY1 downstream of the transcription initiation site can
affect gene expression (Griffioen et al. 2000).
Finally, in order to confirm the effects of YY1 on
18483C allele-mediated transcriptional suppression, report-
er assay was performed under YY1 knockdown conditions.
Briefly, YY1 siRNA or control siRNA was introduced into
THP-1 cells with a reporter plasmid using Nucleofector II
(Amaxa, Cologne, Germany) as described previously
(Maeda et al. 2006). As shown in Fig. 6, luciferase activity
driven by a plasmid carrying the C allele was significantly
upregulated by the introduction of YY1 siRNA, whereas
the other two promoters, basic and carrying the A allele,
were not affected by YY1 siRNA, thus suggesting that
transcriptional suppression depending on the C allele at the
18483 locus is regulated by YY1.
YY1 was previously reported to be involved in regula-
tion of several important allergy-related genes. Briefly,
Silverman et al. (2004) demonstrated that, being associated
with variant YY1 binding and thus altering transcriptional
activity, the 509C>T polymorphism of transforming
growth factor-β
1
was associated with asthma. Guo et al.
(2001) and Mordvinov et al. (1999) showed that YY1
transcription factor regulates T cell cytokine gene expres-
sion and allergic immune responses. Finally, some members
of our group demonstrated the involvement of YY1 in
transcriptional regulation of FcεRI subunit expression. Brief-
ly, variant YY1 factor binding to FcεRI β-subunit (FcεRIβ)
654C>T polymorphism was shown to affect its expression
(Nishiyama et al. 2004). Moreover, YY1 was demonstrated
to contribute to the regulation of FcεRIαtranscription
through proximal and distal promoters (Nishiyama et al.
2001,2002;Hasegawaetal.2003a).
In summary, we demonstrated preferential binding of YY1
to the FcεRIαgene 18483C allele resulting in lower
transcriptional activity. The differences in transcriptional
activity between 18483C and 18483A alleles are not
apparently striking, but they may potentially be of some
biological importance in monocytes in which the potential
effect of 18483A>C variant on the distal promoter would
not be easily masked by strong activity of the proximal
promoter (Hasegawa et al. 2003a) and/or potent influences
of 344C>T/95T>C polymorphisms (Hasegawa et al.
2003b; Bae et al. 2007; Kanada et al. 2008). The
associations between FcεRIαpolymorphism and serum IgE
levels and/or allergic disorders (Shikanai et al. 2002;
Hasegawa et al. 2003b; Potaczek et al. 2006,2007a,
2007b; Bae et al. 2007) may result from haplotypic interplay
between functional (Hasegawa et al. 2003b; Bae et al. 2007;
Kanada et al. 2008)344C>T,
95T>C, and 18483A>C
polymorphisms. A hypothetical mechanism by which alter-
ations in FcεRI(α) expression could affect IgE synthesis/
levels remains unknown. Therefore, further functional
studies focusing on this issue are necessary.
References
Bae JS, Kim SH, Ye YM et al (2007) Significant association of
FcεRIαpromoter polymorphisms with aspirin-intolerant chronic
urticaria. J Allergy Clin Immunol 119:449456
Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and
visualization of LD and haplotype maps. Bioinformatics 21:263265
Griffioen M, Ouwerkerk IJ, Harten V, Schrier PI (2000) HLA-B locus-
specific downregulation in human melanoma requires enhancer
A as well as a sequence element located downstream of the
transcription initiation site. Immunogenetics 52:121128
Guo J, Casolaro V, Seto E et al (2001) Yin-Yang 1 activates
interleukin-4gene expression in T cells. J Biol Chem
276:4887148878
Hasegawa M, Nishiyama C, Nishiyama M et al (2003a) Regulation of
the human FcεRI α-chain distal promoter. J Immunol 170:3732
3738
Hasegawa M, Nishiyama C, Nishiyama M et al (2003b) A novel -
66 T/C polymorphism in FcεRI α-chain promoter affecting the
transcription activity: possible relationship to allergic diseases. J
Immunol 171:19271933
Javahery R, Khachi A, Lo K, Zenzie-Gregory B, Smale ST (1994)
DNA sequence requirements for transcriptional initiator activity
in mammalian cells. Mol Cell Biol 14:116127
654 Immunogenetics (2009) 61:649655
Kanada S, Nakano N, Potaczek DP et al (2008) Two different transcription
factors discriminate the -315C>T-polymorphism of the FcεRI α-
chain gene: binding of Sp1 to -315C and of a high mobility group-
related molecule to -315 T. J Immunol 180:82048210
Maeda K, Nishiyama C, Tokura T et al (2006) FOG-1 represses
GATA-1-dependent FcepsilonRI beta-chain transcription: tran-
scriptional mechanism of mast-cell-specific gene expression in
mice. Blood 108:262269
Mordvinov VA, Schwenger GT, Fournier R et al (1999) Binding of
YY1 and Oct1 to a novel element that downregulates expression
of IL-5 in human T cells. J Allergy Clin Immunol 103:11251135
Nishiyama C, Hasegawa M, Nishiyama M et al (2001) Cloning of
full-length genomic DNA encoding human FcεRI α-chain and its
transcriptional regulation. Biochem Biophys Res Commun
284:10561064
Nishiyama C, Hasegawa M, Nishiyama M et al (2002) Regulation of
human FcεRI α-chain gene expression by multiple transcription
factors. J Immunol 168:45464552
Nishiyama C, Akizawa Y, Nishiyama M et al (2004) Polymorphisms
in the FcεRIβpromoter region affecting transcription activity: a
possible promoter-dependent mechanism for association between
FcεRIβand atopy. J Immunol 173:64586464
Potaczek DP, Sanak M, Mastalerz L et al (2006) The α-chain of high-
affinity receptor for IgE (FcεRIα) gene polymorphisms and
serum IgE levels. Allergy 61:12301233
Potaczek DP, Sanak M, Mastalerz L, Milewski M, Gawlewicz-
Mroczka A, Szczeklik A (2007a) Genetic polymorphisms of the
novel FCER1A gene region: relation to total serum IgE levels.
Ann Allergy Asthma Immunol 98:500501
Potaczek DP, Sanak M, Szczeklik A (2007b) Additive association
between FCER1A and FCER1B genetic polymorphisms and total
serum IgE levels. Allergy 62:10951096
Potaczek DP, Nishiyama C, Sanak M, Szczeklik A, Okumura K,
Ogawa H (2008) FCER1A gene exon 1A polymorphisms in
Japanese and Polish subjectsa comparative analysis of hap-
lotypes. Allergy 63:626627
Shikanai T, Silverman ES, Morse BW, Lilly CM, Inoue H, Drazen JM
(2002) Sequence variants in the FcεRI alpha chain gene. J Appl
Physiol 93:3741
Shrivastava A, Calame K (1994) An analysis of genes regulated by the
multi-functional transcriptional regulator Yin Yang-1. Nucleic
Acids Res 22:51515155
Silverman ES, Palmer LJ, Subramaniam V et al (2004) Trans-
forming growth factor-β
1
promoter polymorphism C509 T is
associated with asthma. Am J Respir Crit Care Med 169:214
219
Tregouet DA, Garelle V (2007) A new JAVA interface implementation
of THESIAS: testing haplotypes effects in association studies.
Bioinformatics 23:10381039
Wang QH, Nishiyama C, Nakano N et al (2008) Suppresive effect of
Elf-1 on FcεRI α-chain expression in primary mast cells.
Immunogenetics 60:557563
Zhang M, Murphy RF, Agrawal DK (2007) Decoding IgE Fc
receptors. Immunol Res 37:116
Immunogenetics (2009) 61:649655 655

Supplementary resource (1)

... The present study is aimed to analyse the promoter areas of 16 genes related to allergic diseases and drug hypersensitivity reactions (DHRs). We have focused on the promoter gene region due to its crucial role in transcriptional activity and expression of the gene, as it has been observed for the SNPs located in the promoter of FCER1A ( Potaczek et al., 2009), or IL13 ( Cameron et al., 2006;Kiesler et al., 2009;Li et al., 2014). The rationale for the selection of the 16 genes included in this study is based on putative mechanisms involved this type of reactions. ...
Article
Full-text available
The prevalence of allergic diseases and drug hypersensitivity reactions (DHRs) during recent years is increasing. Both, allergic diseases and DHRs seem to be related to an interplay between environmental factors and genetic susceptibility. In recent years, a large effort in the elucidation of the genetic mechanisms involved in these disorders has been made, mostly based on case-control studies, and typically focusing on isolated SNPs. These studies provide a limited amount of information, which now can be greatly expanded by the complete coverage that Next Generation Sequencing techniques offer. In this study, we analyzed the promoters of sixteen genes related to the Vitamin D pathway and the high-affinity IgE receptor, including FCER1A, MS4A2, FCER1G, VDR, GC, CYP2R1, CYP27A1, CYP27B1, CYP24A1, RXRA, RXRB, RXRG, IL4, IL4R, IL13, and IL13RA1. The study group was composed of patients with allergic rhinitis plus asthma (AR+A), patients with hypersensitivity to beta-lactams (BLs), to NSAIDs including selective hypersensitivity (SH) and cross-reactivity (CR), and healthy controls without antecedents of atopy or adverse drug reactions. We identified 148 gene variations, 43 of which were novel. Multinomial analyses revealed that three SNPs corresponding to the genes FCER1G (rs36233990 and rs2070901), and GC (rs3733359), displayed significant associations and, therefore, were selected for a combined dataset study in a cohort of 2,476 individuals. The strongest association was found with the promoter FCER1G rs36233990 SNP that alters a transcription factor binding site. This SNP was over-represented among AR+A patients and among patients with IgE-mediated diseases, as compared with control individuals or with the rest of patients in this study. Classification models based on the above-mentioned SNPs were able to predict correct clinical group allocations in patients with DHRs, and patients with IgE-mediated DHRs. Our findings reveal gene promoter SNPs that are significant predictors of drug hypersensitivity, thus reinforcing the hypothesis of a genetic predisposition for these diseases.
... 23,30,48,49 Many SNPs associated with atopy localized in the regulatory sequences of the 5?-flanking region and 5?- untranslated region (5?-UTR) influence transcriptional activity of the Fc?R1? gene and the subsequent receptor expression along with serum IgE levels. 23,[25][26][27]44,50 We examined five SNPs in the Fc?R1? gene region for associations with the risk of CRSwNP outcome, and found significant association of SNP rs2427827 with high serum IgE levels in CRSwNP cases which is concordant with many previous reports showing rs2427827 polymorphism association with atopy and with serum IgE levels in allergic patients. [24][25][26]44 This SNP has been found to be associated with higher proximal promoter activity in mast cell line, creating binding motif for MAZ transcriptional factor and higher histamine release form peripheral basophils obtained from aspirin-induced chronic urticaria patients. ...
Article
Despite large number of investigations, the etiology of chronic rhinosinusitis (CRS) remains unclear. Several factors are likely involved in its onset. The genetic susceptibility of IgE-responsiveness likely caused by polymorphism(s) in high affinity receptor for IgE (FcεR1α) gene can help in understanding the pathophysiology of CRS with nasal polyposis (CRSwNP). A population-based case-control association analysis was conducted to assess the risk of CRSwNP conferred by single nucleotide polymorphisms (SNPs) in FcεR1α gene in a North Indian cohort. Two promoter and three exonic regions of FcεR1α gene were amplified and sequenced to investigate five SNPs - rs2427827, rs2251746, rs2298804, rs2298805, and rs2269718. BLAST analysis and subsequent multiple alignments, with known sequences available in the NCBI database, were performed. Total serum IgE and FcεR1α antibody levels were estimated. Patient IgE level of 461.22 ± 436.43 in comparison to 83.62 ± 58.043 IU/mL in controls (p < 0.0001), and FcεR1α antibody level of 292.38 ± 115.27 in comparison to 160.56 ± 105.9 in controls (p < 0.0001), depicts their highly significant associations with CRSwNP disease. However, no SNP showed evidence of association with CRSwNP; although relatively higher Odds ratios were observed with rs2427827, rs2251746 and rs2298804. Patient stratification revealed a significant association (p < 0.05) of rs2427827 SNP with high IgE level CRSwNP patients. Nonetheless, we found no SNP associated with low serum IgE level patients. SNP (rs2427827) in the FcεR1α gene region and high IgE levels may confer susceptibility to CRSwNP in north Indian population. However, further studies including larger sample size, gene-gene and gene-environment interactions are required for its elucidation. This article is protected by copyright. All rights reserved.
... see Table I; CI, confidence interval. also reported to functionally affect transcriptional activity as described in more details elsewhere (21)(22)(23). ...
Article
Background Recently, three genome-wide association studies (GWAS) demonstrated FCER1A, the gene encoding a ligand-binding subunit of the high-affinity IgE receptor, to be a major susceptibility locus for serum IgE levels. The top association signal differed between the two studies from the general population and the one based on an asthma case-control design. In this study, we investigated whether different FCER1A polymorphisms are associated with total serum IgE in the general population and asthmatics specifically. Methods Nineteen polymorphisms were studied in FCER1A based on a detailed literature search and a tagging approach. Polymorphisms were genotyped by the Illumina HumanHap300Chip (6 polymorphisms) or MALDI-TOF MS (13 polymorphisms) in at least 1303 children (651 asthmatics) derived from the German International Study of Asthma and Allergies in Childhood II and Multicentre Asthma Genetics in Childhood Study. ResultsSimilar to two population-based GWAS, the peak association with total serum IgE was observed for SNPs rs2511211, rs2427837, and rs2251746 (mean r(2)>0.8), with the lowest p-value of 4.37x10(-6). The same 3 polymorphisms showed the strongest association in non-asthmatics (lowest p=0.0003). While these polymorphisms were also associated with total serum IgE in asthmatics (lowest p=0.003), additional polymorphisms (rs3845625, rs7522607, and rs2427829) demonstrated associations with total serum IgE in asthmatics only (lowest p=0.01). Conclusions These data suggest that FCER1A polymorphisms not only drive IgE levels in the general population but that specific polymorphisms may also influence IgE in association with asthma, suggesting that disease-specific mechanisms in IgE regulation exist.
... In addition, the frequent 218483A.C (rs2494262) polymorphism was also found to be associated with total serum IgE levels in allergic subjects181920. Very recently, Potaczek et al found that we confirmed preferential binding of the YY1 transcription factor to the 218483C allele, resulting in lower transcriptional activity when compared with the 218483A allele [26]. Total IgE is a strongly heritable quantitative trait [27,28]. ...
Article
Full-text available
Immunoglobulin E (IgE) is a central player in the allergic response, and raised total IgE levels are considered as an indicator of atopy or potential development of atopy. A recent genome-wide scan in a German population-based cohort of adults identified the gene encoding the alpha chain of the high affinity receptor for IgE (FCER1A) as a susceptibility locus influencing total serum IgE levels. The aim of this study was to investigate whether the polymorphisms in the FCER1A gene are associated with allergic rhinitis (AR) in a Han Chinese population. A population of 378 patients with AR and 288 healthy controls was studied. Precise phenotyping of patients was accomplished by means of a questionnaire and clinical examination. Blood was drawn for DNA extraction and total serum immunoglobulin E (IgE) measurement. A total of 16 single nucleotide polymorphisms (SNPs) in FCER1A were selected and individually genotyped. None of the SNPs in the FCER1A showed an association with AR. Similarly, the lack of association was also evident in subgroup analysis for the presence of different allergen sensitivities. None of the selected SNPs in FCER1A was associated with total IgE level. Although FCER1A presents itself as a good candidate for contributing to total serum IgE, this study failed to find an association between SNPs in the FCER1A gene region and IgE level or AR susceptibility.
Article
Background Asthma is a common immune disorder characterized by increased IgE levels. The interleukin (IL)-4 and IL-13 pathway is central for IgE regulation, and previous studies have reported many genetic variants of IL-4/IL-13 signaling in relation to asthma, but few have focused on the gene-to-gene interactions that are likely to contribute to disease complexity. Objective To assess the combined effects of 7 functional single-nucleotide polymorphisms (SNPs) on asthma susceptibility, total serum IgE levels, and gene expression in children. Methods Seven SNPs (rs2243250, rs1800925, rs1805010, rs324011, rs2251746, rs2494262, and rs2427837) were genotyped children with asthma (n = 500) and a control group (n = 523), and total serum IgE levels and gene expressions were measured in children with asthma. Results Children with asthma had a likelier possibility of carrying more risk genotypes. Mean IgE levels increased from the minimum of 71.07 KU/L in children with no tested polymorphisms to a maximum of 901.7 KU/L in children carrying 7 risk genotypes. Gene expression analysis showed that patients with 4 SNPs (rs2243250, rs1800925, rs1805010, and rs3224011) had higher expression levels of IL-4, IL-13, and STAT6. Moreover, serum IgE level generally correlated well with IL-4 (r = 0.236, P = .011) and IL-13 (r = 0.211, P = .021) expressions; IL-4 expression correlated positively with IL-13 (r = 0.962, P = .000) and STAT6 (r = 0.190, P = .022) expressions, and STAT6 expression correlated with IL-4RA expression (r = 0.904, P = .000). Conclusion These data suggest that combinations of multiple SNPs might magnify the impact on disease risk. Only a combined analysis of the variants in the IL-4/IL-13 pathway could show the functional interplay of multiple genes in asthma.
Article
In addition to a well-known immunologic background of atherosclerosis and influences of inflammation on arterial and venous thrombosis, there is growing evidence for the presence of links between allergy and vascular or thrombotic disorders. In this interpretative review, five pretty well-documented areas of such overlap are described and discussed, including: (1) links between atherosclerosis and immunoglobulin E or atopy, (2) mutual effects of blood lipids and allergy, (3) influence of atopy and related disorders on venous thromboembolism, (4) the role of platelets in allergic diseases, and (5) the functions of protein C system in atopic disorders.
Article
Epidermal Langerhans cells (LC) expressing the high-affinity receptor for IgE (FcεRI) play a key role in atopic dermatitis (AD). AD skin is highly colonized with Staphylococcus aureus (S.a.), which are sensed by Toll-like receptor 2 (TLR2). We hypothesized that TLR2 may impact on the expression of FcεRI on LC. To study a putative impact of TLR2 signaling on FcεRI, we analyzed FcεRI and known transcription factors of the receptor after ligand binding to TLR2. We generated LC from CD34+ progenitors in vitro (CD34LC) expressing FcεRI and TLR2 as well as its partners TLR1 and TLR6. The expression of FcεRI and known transcription factors of the receptor was analyzed on the protein and RNA level by flow cytometry, Western blotting, and real-time PCR. For CD34LC from 123 donors, we observed a high heterogeneity in FcεRI surface expression correlating with mRNA level of its α-chain. Stimulation of TLR1/2 or TLR2/6 dramatically down-regulated FcεRI on protein and mRNA level of both α- and γ-chain. Further analysis of putative transcription factors for FCER1A revealed the lack of GATA1 in CD34LC, weak expression of ELF1 and YY1, and high expression of PU.1. While ELF1 and YY1 appeared to be little affected by TLR2 engagement, PU.1 was significantly down-regulated. Taken together, our findings show that in human, LC ligation of TLR2 by S.a.-derived products down-regulates FcεRI and its transcription factor PU.1, thus suggesting that FcεRI is controlled by PU.1 in these cells.
Article
Immunoglobulin E (IgE) mediated immune responses seem to be directed against parasites and neoplasms, but are best known for their involvement in allergies. The IgE network is tightly controlled at different levels as outlined in this review. Genetic determinants were suspected to influence IgE regulation and IgE levels considerably for many years. Linkage and candidate gene studies suggested a number of loci and genes to correlate with total serum IgE levels, and recently genome-wide association studies (GWAS) provided the power to identify genetic determinants for total serum IgE levels: 1q23 (FCER1A), 5q31 (RAD50, IL13, IL4), 12q13 (STAT6), 6p21.3 (HLA-DRB1) and 16p12 (IL4R, IL21R). In this review, we analyse the potential role of these GWAS hits in the IgE network and suggest mechanisms of how genes and genetic variants in these loci may influence IgE regulation.
Article
The high affinity immunoglobulin E (IgE) receptor (FcεRI) plays a key role in the pathogenesis of atopy and allergic disorders. Several polymorphisms located in 5'-flanking region and 5'-untranslated region (5'-UTR) of human FCER1A, the gene encoding FcεRI α-subunit, have been shown to functionally affect its transcriptional activity. All those genetic variants have been also associated with allergic diseases and/or serum IgE levels. In the present study, we sought to identify functional polymorphisms in human FCER1A 3'-untranslated region (3'-UTR), the potential candidates for future genetic association studies. Search for polymorphisms within human FCER1A 3'-UTR region, conducted in Japanese and Poles, revealed the presence of +5650A>G and +5714G>A variants. Subsequently, structure/distribution of haplotypes and LD measures were analyzed in Japanese and Poles for both 3'-UTR variants and the functional polymorphisms located in 5'-flanking region and 5'-UTR of human FCER1A. Additionally, reporter plasmids containing human FCER1A main promoter and 3'-UTR with all four possible combinations of +5650A>G and +5714G>A polymorphisms were constructed to evaluate functional potential of both 3'-UTR variants. However, no genotype-related differences in the gene expression were observed, as measured by reporter activity in cultured human basophil/mast cell-like KU812 cells, suggesting that both +5650A>G and +5714G>A have no genotype-related functional effect. In summary, we described linkage disequilibrium and the distribution of haplotypes for two identified human FCER1A 3'-UTR polymorphisms and several previously reported 5'-flanking region and 5'-UTR variants in Japanese and Poles, representative for East Asians and Caucasians, the two ethnic groups in which genetic associations between FCER1A and allergic diseases and/or serum IgE levels have been previously reported.
Article
Full-text available
The β subunit of the high-affinity IgE receptor (FcεRI) plays an important role in IgE-mediated allergic reactions as an amplifier for cell surface expression and signal transduction of FcεRI. FcεRIβ is presumed to be one of the genes linked with atopic diseases. However, the validity of the associations previously found between single nucleotide polymorphisms (SNPs) in FcεRIβ and atopic diseases is questionable. In the present study, we found correlation between the SNP of FcεRIβ at +6960A/G, resulting in a Glu237Gly amino acid substitution, and the cell surface expression level of FcεRI on blood basophils, although it has been shown that the Glu237Gly mutation itself does not affect the surface expression or function of FcεRI. We additionally found four SNPs in the promoter region of FcεRIβ, among which −426T/C and −654C/T were tightly linked with +6960A/G. Reporter plasmids carrying the −426C and −654T promoter displayed higher transcriptional activity than those carrying the −426T and −654C promoter. We found that transcription factor YY1 preferentially bound and transactivated the −654T promoter. Furthermore, expression of FcεRI β-chain mRNA in basophils from individuals who have the minor heterozygous genotype was significantly higher than that of the major homozygous genotype. These results suggest that the SNPs in the FcεRIβ promoter are causally linked with atopy via regulation of FcεRI expression.
Article
Full-text available
The alpha-chain is a specific component of FcepsilonRI, which is essential for the cell surface expression of FcepsilonRI and the binding of IgE. Recently, two single nucleotide polymorphisms (SNPs) in the alpha-chain promoter, -315C>T and -66T>C, have been shown by statistic studies to associate with allergic diseases. The effect of -66 SNP on GATA-1-mediated promoter activity has been already indicated. In the present study, to investigate roles of the -315 SNP on the alpha-chain promoter functions, the transcription activity was evaluated by reporter assay. The alpha-chain promoter carrying -315T (minor allele) possessed significantly higher transcriptional activity than that of -315C (major allele). EMSA indicated that the transcription factor Sp1, but not Myc-associated zinc finger protein (MAZ), was bound to the -315C allele probe and that a transcription factor belonging to a high mobility group-family bound to the -315T allele probe. The chromatin immunoprecipitation assay suggested that high mobility group 1, 2, and Sp1 bound around -315 of FcepsilonRIalpha genomic DNA in vivo in the human basophil cell line KU812 with -315C/T and in human peripheral blood basophils with -315C/C, respectively. When cell surface expression level of FcepsilonRI on basophils was analyzed by flow cytometry, basophils from individuals carrying -315T allele expressed significantly higher amount of FcepsilonRI compared with those of -315C/C. The findings demonstrate that a -315 SNP significantly affects human FcepsilonRI alpha-chain promoter activity and expression level of FcepsilonRI on basophils by binding different transcription factors to the SNP site.
Article
Full-text available
IL-5 controls development of eosinophilia and has been shown to be involved in the pathogenesis of allergic diseases. In both atopic and nonatopic asthma, elevated IL-5 has been detected in peripheral blood and the airways. IL-5 is produced mainly by activated T cells, and its expression is regulated at the transcriptional level. This study focuses on the functional analysis of the human IL-5 (hIL-5) promoter and characterization of cis -regulatory elements and transcription factors involved in the suppression of IL-5 transcription in T cells. Methods used in this study include DNase I footprint assays, electrophoretic mobility shift assays, and functional analysis by mammalian cell transfection involving deletion analysis and site-directed mutagenesis. We identified 5 protein binding regions (BRs) located within the proximal hIL-5 promoter. Functional analysis indicates that the BRs are involved in control of hIL-5 promoter activity. Two of these regions, BR3 and BR4 located at positions -102 to -73, have not previously been described as regulators of IL-5 expression in T cells. We show that the BR3 sequence contains a novel negative regulatory element located at positions -90 to -79 of the hIL-5 promoter, which binds Oct1, octamer-like, and YY1 nuclear factors. Substitution mutations, which abolished binding of these proteins to the BR3 sequence, significantly increased hIL-5 promoter activity in activated T cells. We suggest that Oct1, YY1, and octamer-like factors binding to the -90/-79 sequence within the proximal IL-5 promoter are involved in suppression of IL-5 transcription in T cells.
Article
Full-text available
Interleukin-4 (IL-4) is a multifunctional cytokine that plays an important role in immune and inflammatory responses. Expression of the IL-4 gene is tightly controlled at the level of gene transcription by both positive and negative regulatory elements in the IL-4 promoter. Several constitutive nuclear factors have been identified that can interact with IL-4 promoter elements in DNA binding assays. Here we report that the zinc-finger protein YY-1 (Yin-Yang 1) can bind to multiple elements within the human IL-4 promoter. Cotransfection of Jurkat T cells with different IL-4 promoter/reporter constructs together with expression vectors encoding antisense, wild-type, or zinc finger-deleted mutant YY-1 suggested that YY-1 enhanced IL-4 promoter activity in a DNA-binding domain-dependent manner. Site-directed mutagenesis revealed that a proximal YY-1-binding site, termed Y0 (−59TCATTTT−53), was essential for YY-1-driven IL-4 promoter activity. In addition, cotransfected YY-1 enhanced both IL-4 promoter activity and endogenous IL-4 gene expression in nontransformed peripheral blood T cells. Thus, YY-1 positively regulates IL-4 gene expression in lymphocytes.
Article
The high-affinity receptor for immunoglobulin E (IgE), FcepsilonRI, is specifically expressed in mast cells and basophils and plays a key role in IgE-mediated allergic reactions. The transcription factor Elf-1 has been previously identified to bind to the promoter of the human FcepsilonRI alpha-chain, which is essential for the function and expression of FcepsilonRI. In the present study, Elf-1 siRNA was conducted to evaluate the effects of Elf-1 on FcepsilonRI alpha-chain expression in the primary mouse mast cells, bone marrow-derived mast cells (BMMC). Introduction of Elf-1 siRNA effectively reduced expression levels of Elf-1 mRNA and protein in BMMC. Transient reporter assay showed that the knockdown of Elf-1 by siRNA resulted in increased FcepsilonRI alpha-chain promoter activity, while overexpression of Elf-1 suppressed alpha-chain promoter activity in BMMC. Elf-1 siRNA-treated BMMC exhibited marked upregulation of FcepsilonRI alpha-chain transcription, whereas beta-chain mRNA was not affected by Elf-1 siRNA. Chromatin immunoprecipitation assay showed that the amount of transcription factor PU.1, recognizing the cis-element close to the Elf-1-site on the FcepsilonRI alpha-chain promoter, was significantly increased by introduction of Elf-1 siRNA. These results indicate that Elf-1 negatively regulates FcepsilonRI alpha-chain expression by suppressing PU.1-mediated transcription of the alpha-chain in BMMC.
Article
A transcriptional initiator (Inr) for mammalian RNA polymerase II can be defined as a DNA sequence element that overlaps a transcription start site and is sufficient for (i) determining the start site location in a promoter that lacks a TATA box and (ii) enhancing the strength of a promoter that contains a TATA box. We have prepared synthetic promoters containing random nucleotides downstream of Sp1 binding sites to determine the range of DNA sequences that convey Inr activity. Numerous sequences behaved as functional Inrs in an in vitro transcription assay, but the Inr activities varied dramatically. An examination of the functional elements revealed loose but consistent sequence requirements, with the approximate consensus sequence Py Py A+1 N T/A Py Py. Most importantly, almost every functional Inr that has been described fits into the consensus sequence that we have defined. Although several proteins have been reported to bind to specific Inrs, manipulation of those elements failed to correlate protein binding with Inr activity. The simplest model to explain these results is that all or most Inrs are recognized by a universal binding protein, similar to the functional recognition of all TATA sequences by the same TATA-binding protein. The previously reported proteins that bind near specific Inr elements may augment the strength of an Inr or may impart transcriptional regulation through an Inr.
Article
Human MHC class I molecules are encoded by three different loci (HLA-A, -B, and -C), which are regulated at the transcriptional level through several conserved cis-acting promoter elements. The presence of locus-specific residues throughout the entire promoter region strongly suggests that the various HLA class I loci are differentially regulated. To identify regulatory sequences involved in locus-specific HLA class I gene transcription, a series of truncated HLA-A2 and HLA-B7 promoter-reporter constructs were transfected into melanoma cell lines expressing high and low levels of endogenous HLA-B, but comparable levels of HLA-A. These experiments showed that differential regulation of HLA-B expression in melanoma cell lines is mediated by a previously unidentified co-operative action of enhancer A, located 175 bp upstream of the transcription initiation site (+1), and a specific region of 20 nucleotides located at +13 to +33 bp downstream of the transcription initiation site. Furthermore, we demonstrated binding of transcription factor Yin Yang 1 to the HLA-A +13/+33 bp region, but not to the equivalent HLA-B region. Based on these results, we present a model suggesting that YY1 displaces either activating or repressing transcription factors, thereby making the HLA-A gene resistant to differential regulation.
Article
Two novel exons, named exon 1A and exon 2A, were found at 18.4 and 12.6 kb upstream from the exon known as the first exon of human FcepsilonRI alpha-chain gene. Transcription from the promoter present in the upstream of exon 1A was decreased by mutations introduced into the "first intron" between exon 1A and exon 2A, suggesting the presence of an intronic regulatory element in the intron. Consistent with this, electrophoretic mobility shift assay revealed the presence of a nuclear factor which bound the region in FcepsilonRI alpha-chain positive cells.